Delivery Order SPE2DB24D2205-SPE2DB25FEGBX
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Venclexta 100 mg tablets in quantities of 120 units. This firm fixed price delivery order, valued at $58,369.02, represents a non-competitive, non-set-aside award and is scheduled for completion by August 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Venclexta 100 mg tablets in quantities of 120 units. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $4,579.40 to AmerisourceBergen Drug Corp for 28 units of Venclexta 100 mg tablets. This contract, executed on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a firm fixed price delivery order with no set-aside designation. The order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award is issued as a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VENCLEXTA 100 mg tablets (120-count units) valued at $9,728.17 under a firm fixed-price contract type. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Venclexta 50 mg tablet unit dose packages (quantity 7). This non-set-aside, competitively awarded contract is valued at $1,743.06 with a firm fixed price and is scheduled for completion by September 4, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,880.15 firm fixed-price delivery order is for the supply of Venclexta 100 mg tablets. The contract has an ultimate completion date of April 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of VENCLEXTA 100 mg tablets (120 count), valued at $9,728.17. This firm fixed-price, competitively awarded delivery order is expected to be completed by August 14, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's demonstrated...
- The Defense Logistics Agency awarded a $9,728.17 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Venclexta 100 mg on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through an open process. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a Delivery Order valued at $19,456.34 to AmerisourceBergen Drug Corp for 120 tablets of Venclexta 100 mg, a pharmaceutical product for blood cancer treatment. Issued on August 13, 2025, with an ultimate completion date of September 4, 2025, this firm fixed-price contract represents a non-competitive award to the established vendor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,760.30 firm-fixed-price contract is for the delivery of the medication Venclexta 100 mg tablets. The ultimate completion date is December 6, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGBXDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $9,728.17 by the Defense Logistics Agency (DLA) for the supply of Venclexta 100 mg tablets (120-count units), with a firm fixed price structure and an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026. AmerisourceBergen Drug Corp, one of the nation's major pharmaceutical distributors, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. As a prime vendor under the DLA Troop Support Medical contract vehicle, the company supplies an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. This specific delivery order for Venclexta, a oncology medication, reflects the company's ongoing role in fulfilling specialized pharmaceutical needs across the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 8/11/25 |